Company: IMRX
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001790340-25-000104
Chunk: 320

Company: Immuneering Corp
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 320
---
Item 1. Financial Statements

IMMUNEERING CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

June 30, 2025December 31, 2024AssetsCurrent assets:Cash and cash equivalents$26,355,498 $36,144,720 Prepaids and other current assets1,369,928 3,442,849 Total current assets27,725,426 39,587,569 Property and equipment, net964,138 1,122,865 Goodwill6,690,431 6,690,431 Intangible asset, net335,780 350,413 Right-of-use assets, net3,498,967 3,667,352 Other assets841,726 1,295,783 Total assets$40,056,468 $52,714,413 Liabilities and Stockholders' EquityCurrent liabilities:Accounts payable$2,395,203 $1,958,536 Accrued expenses4,514,960 4,973,129 Other liabilities209,708 233,665 Lease liabilities366,959 338,438 Total current liabilities7,486,830 7,503,768 Long-term liabilities:Lease liabilities, net of current portion3,633,601 3,824,419 Total liabilities11,120,431 11,328,187 Commitments and contingencies (Note 10)Stockholders’ equity:Preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2025 and December 31, 2024; 0 shares issued or outstanding at June 30, 2025 and December 31, 2024— — Class A common stock, $0.001 par value, 200,000,000 shares authorized at June 30, 2025 and December 31, 2024; 35,987,306 and 31,050,448 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively35,987 31,050 Class B common stock, $0.001 par value, 20,000,000 shares authorized at June 30, 2025 and December 31, 2024; 0 shares issued and outstanding at June 30, 2025 and December